DRIEHAUS CAPITAL MANAGEMENT LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 80 filers reported holding XENON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DRIEHAUS CAPITAL MANAGEMENT LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$154,164,251
-15.9%
4,513,005
-5.2%
2.00%
-13.4%
Q2 2023$183,292,841
+10.0%
4,760,853
+2.3%
2.31%
-1.0%
Q1 2023$166,599,766
-9.8%
4,654,925
-0.6%
2.34%
-15.0%
Q4 2022$184,603,256
+13.5%
4,681,797
+3.9%
2.75%
+11.8%
Q3 2022$162,595,000
+21.7%
4,504,020
+2.6%
2.46%
+13.8%
Q2 2022$133,575,000
+32.4%
4,391,038
+33.0%
2.16%
+74.7%
Q1 2022$100,894,000
+3.4%
3,300,427
+5.7%
1.24%
+24.4%
Q4 2021$97,570,000
+322.5%
3,123,229
+106.6%
1.00%
+263.5%
Q3 2021$23,096,000
+31.2%
1,511,543
+59.9%
0.27%
+17.6%
Q2 2021$17,598,000
+27.4%
945,135
+22.5%
0.23%
+14.2%
Q1 2021$13,808,000
+101.5%
771,410
+73.2%
0.20%
+83.8%
Q4 2020$6,851,000
+37.1%
445,444
-1.3%
0.11%
+7.8%
Q3 2020$4,996,000
-14.2%
451,307
-2.8%
0.10%
-27.5%
Q2 2020$5,821,000
+11.0%
464,233
+0.4%
0.14%
-18.9%
Q1 2020$5,243,000462,3320.18%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders